Department of Obstetrics and Gynecology, Harbor-UCLA Medical Center, 1000 West Carson Street, Box 474, Torrance, CA 90509, USA.
Obstet Gynecol Clin North Am. 2013 Sep;40(3):413-27. doi: 10.1016/j.ogc.2013.05.001. Epub 2013 Jul 25.
The number of women diagnosed with breast cancer continues to increase, but mortality rates have substantially declined. Much of the credit for this decline has been attributed to early detection from mammographic screening. However, there are significant controversies about the effectiveness of all screening tools for breast cancer, concerns about the potential harm that can result from screening, and questions about the appropriateness of screening recommendations. One of the greatest barriers to achieving consensus is the lack of agreement about the purpose of screening efforts. This article reviews many of the current controversies and attempts to clarify the arguments.
被诊断患有乳腺癌的妇女人数持续增加，但死亡率已大幅下降。这种下降在很大程度上归因于通过乳房 X 光筛查实现的早期发现。然而，对于所有乳腺癌筛查工具的有效性仍存在重大争议，人们担心筛查可能带来的潜在危害，并对筛查建议的适当性提出质疑。达成共识的最大障碍之一是对筛查工作目的缺乏共识。本文回顾了当前的许多争议，并试图澄清这些争议。
